GLP-1 Drugs May Treat & Prevent Addiction to Multiple Substances: Study
New research published this week indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, initially developed for type 2 diabetes, demonstrate a surprising potential in treating and preventing a broad spectrum of ... Read More